Need for Supplemental Oxygen at Discharge in Infants with Bronchopulmonary Dysplasia Is Not Associated with Worse Neurodevelopmental Outcomes at 3 Years Corrected Age
Objectives To determine if chronic oxygen dependency (discharge home on supplemental oxygen) in children with bronchopulmonary dysplasia (BPD; defined as requirement for supplemental O2 at 36 weeks postmenstrual age) predicts neurodevelopmental disability rates and growth outcomes at 36 months corrected age (CA). Study Design Longitudinal cohort study. Setting Southern Alberta regional center located at high altitude. Participants Preterm infants weighing ≤1250 grams with no BPD, BPD, and BPD with chronic oxygen dependency. Main outcome measures Neurodevelopmental and growth outcomes. Results Of 1563 preterm infants admitted from 1995–2007, 1212 survived. Complete follow-up data were available for 1030 (85%) children. Children in BPD and BPD with chronic oxygen dependency groups had significantly lower birth weights, gestational ages, prolonged mechanical ventilation and oxygen supplementation and received more postnatal steroids, compared to those without BPD. Children with BPD and BPD with chronic oxygen dependency were more likely to be below the 5th centile in weight and height compared to those without BPD but there was little difference between the BPD and BPD with chronic oxygen dependency groups. After controlling for confounding variables, children who had BPD and BPD with chronic oxygen dependency had higher odds of neurodevelopmental disability compared to those without BPD [OR (odds ratio) 1.9 (95%CI 1.1 to 3.5) and OR 1.8 (1.1 to 2.9), respectively], with no significant difference between BPD and BPD with chronic oxygen dependency [OR 0.9 (95% CI 0.6 to 1.5)]. Conclusions BPD and BPD with chronic oxygen dependency in children predicts abnormal neurodevelopmental outcomes at 36 months CA. However, the neurodevelopmental disability rates were not significantly higher in BPD with chronic oxygen dependency children compared to children with BPD only. Compared to those without BPD, growth is impaired in children with BPD and BPD with chronic oxygen dependency, but no difference between the latter two groups.
References
[1]
Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, et al. (2005) Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116: 1353–1360. doi: 10.1542/peds.2005-0249
[2]
Vohr BR, Wright LL, Dusick AM, Perritt R, Poole WK, et al. (2004) Center differences and outcomes of extremely low birth weight infants. Pediatrics 113: 781–789. doi: 10.1542/peds.113.4.781
[3]
Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, et al. (2000) Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 105: 1194–1201. doi: 10.1542/peds.105.6.1194
[4]
Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM (1988) Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 82: 527–532.
[5]
Northway WH Jr, Rosan RC, Porter DY (1967) Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276: 357–368. doi: 10.1056/nejm196702162760701
[6]
Singer L, Martin RJ, Hawkins SW, Benson-Szekely LJ, Yamashita TS, et al. (1992) Oxygen desaturation complicates feeding in infants with bronchopulmonary dysplasia after discharge. Pediatrics 90: 380–384.
Short EJ, Klein NK, Lewis BA, Fulton S, Eisengart S, et al. (2003) Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 112: e359. doi: 10.1542/peds.112.5.e359
[9]
Fitzgerald DA, Massie RJ, Nixon GM, Jaffe A, Wilson A, et al. (2008) Infants with chronic neonatal lung disease: recommendations for the use of home oxygen therapy. Med J Aust 189: 578–582.
[10]
Majnemer A, Riley P, Shevell M, Birnbaum R, Greenstone H, et al. (2000) Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors. Dev Med Child Neurol 42: 53–60. doi: 10.1017/s001216220000013x
[11]
Trittmann JK, Nelin LD, Klebanoff MA (2013) Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates. Eur J Pediatr 172: 1173–1180. doi: 10.1007/s00431-013-2016-5
[12]
Blishen B, Carroll W, Moore C (1987) The 1981 socioeconomic index for occupations in Canada. Canad Rev Soc & Anth 24(4): 465–488. doi: 10.1111/j.1755-618x.1987.tb00639.x
[13]
Lodha A, Zhu Q, Lee SK, Shah PS (2011) Neonatal outcomes of preterm infants in breech presentation according to mode of birth in Canadian NICUs. Postgrad Med J 87: 175–179. doi: 10.1136/pgmj.2010.107532
[14]
Routine screening cranial ultrasound examinations for the prediction of long term neurodevelopmental outcomes in preterm infants. Paediatr Child Health 6: 39–52.
Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, et al.. (2000) CDC growth charts: United States. Adv Data: 1–27.
[17]
Whitehead J (1993) Sample size calculations for ordered categorical data. Stat Med 12: 2257–2271. doi: 10.1002/sim.4780122404
[18]
Lagatta J, Clark R, Spitzer A (2012) Clinical predictors and institutional variation in home oxygen use in preterm infants. J Pediatr 160: 232–238. doi: 10.1016/j.jpeds.2011.08.033
[19]
Hennessy EM, Bracewell MA, Wood N, Wolke D, Costeloe K, et al. (2008) Respiratory health in pre-school and school age children following extremely preterm birth. Arch Dis Child 93: 1037–1043. doi: 10.1136/adc.2008.140830
[20]
Lee SK, Ye XY, Singhal N, De La Rue S, Lodha A, et al.. (2012) Higher Altitude and Risk of Bronchopulmonary Dysplasia among Preterm Infants. Am J Perinatol.
[21]
Madden J, Kobaly K, Minich NM, Schluchter M, Wilson-Costello D, et al. (2010) Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia. J Perinatol 30: 103–111. doi: 10.1038/jp.2009.142
[22]
Wang LY, Luo HJ, Hsieh WS, Hsu CH, Hsu HC, et al. (2010) Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants. Pediatr Pulmonol 45: 165–173. doi: 10.1002/ppul.21171
[23]
Lewis BA, Singer LT, Fulton S, Salvator A, Short EJ, et al. (2002) Speech and language outcomes of children with bronchopulmonary dysplasia. J Commun Disord 35: 393–406. doi: 10.1016/s0021-9924(02)00085-0
[24]
Singer LT, Siegel AC, Lewis B, Hawkins S, Yamashita T, et al. (2001) Preschool language outcomes of children with history of bronchopulmonary dysplasia and very low birth weight. J Dev Behav Pediatr 22: 19–26. doi: 10.1097/00004703-200102000-00003
[25]
Bhandari A, Bhandari V (2009) Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 123: 1562–1573. doi: 10.1542/peds.2008-1962
[26]
Bhandari V (2013) The potential of non-invasive ventilation to decrease BPD. Semin Perinatol 37: 108–114. doi: 10.1053/j.semperi.2013.01.007
[27]
Botet F, Figueras-Aloy J, Miracle-Echegoyen X, Rodriguez-Miguelez JM, Salvia-Roiges MD, et al. (2012) Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia. BMC Pediatr 12: 63. doi: 10.1186/1471-2431-12-63
[28]
Bhandari V (2010) Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med 15: 223–229. doi: 10.1016/j.siny.2010.03.009
[29]
Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, et al. (2010) Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 362: 1959–1969. doi: 10.1056/nejmoa0911781
[30]
Stenson BJ, Tarnow-Mordi WO, Darlow BA, Simes J, Juszczak E, et al. (2013) Oxygen saturation and outcomes in preterm infants. N Engl J Med 368: 2094–2104.
[31]
Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, et al. (2013) Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. Jama 309: 2111–2120. doi: 10.1001/jama.2013.5555
[32]
Bizzarro MJ, Li FY, Katz K, Shabanova V, Ehrenkranz RA, et al.. (2013) Temporal quantification of oxygen saturation ranges: an effort to reduce hyperoxia in the neonatal intensive care unit. J Perinatol.
[33]
Nesterenko TH, Nolan B, Hammad TA, Aly H (2008) Exposure to oxygen and head growth in infants with bronchopulmonary dysplasia. Am J Perinatol 25: 251–254. doi: 10.1055/s-2008-1075038
[34]
Karagianni P, Tsakalidis C, Kyriakidou M, Mitsiakos G, Chatziioanidis H, et al. (2011) Neuromotor outcomes in infants with bronchopulmonary dysplasia. Pediatr Neurol 44: 40–46. doi: 10.1016/j.pediatrneurol.2010.07.008
[35]
Natarajan G, Pappas A, Shankaran S, Kendrick DE, Das A, et al. (2012) Outcomes of extremely low birth weight infants with bronchopulmonary dysplasia: impact of the physiologic definition. Early Hum Dev 88: 509–515. doi: 10.1016/j.earlhumdev.2011.12.013
[36]
Jeng SF, Hsu CH, Tsao PN, Chou HC, Lee WT, et al. (2008) Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants. Dev Med Child Neurol 50: 51–57. doi: 10.1111/j.1469-8749.2007.02011.x
[37]
Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, et al. (2003) Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. Jama 289: 1124–1129. doi: 10.1001/jama.289.9.1124
[38]
Van Marter LJ, Kuban KC, Allred E, Bose C, Dammann O, et al. (2011) Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch Dis Child Fetal Neonatal Ed 96: F20–29. doi: 10.1136/adc.2010.183012
[39]
Sola A, Rogido MR, Deulofeut R (2007) Oxygen as a neonatal health hazard: call for detente in clinical practice. Acta Paediatr 96: 801–812. doi: 10.1111/j.1651-2227.2007.00287.x
[40]
Sedowofia K, Giles D, Wade J, Cunningham S, McColm JR, et al. (2008) Myelin expression is altered in the brains of neonatal rats reared in a fluctuating oxygen atmosphere. Neonatology 94: 113–122. doi: 10.1159/000119721
[41]
Laughon M, O’Shea MT, Allred EN, Bose C, Kuban K, et al. (2009) Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks’ gestation. Pediatrics 124: 637–648. doi: 10.1542/peds.2008-2874
[42]
Short EJ, Kirchner HL, Asaad GR, Fulton SE, Lewis BA, et al. (2007) Developmental sequelae in preterm infants having a diagnosis of bronchopulmonary dysplasia: analysis using a severity-based classification system. Arch Pediatr Adolesc Med 161: 1082–1087. doi: 10.1001/archpedi.161.11.1082
[43]
Anderson PJ, Doyle LW (2006) Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Perinatol 30: 227–232. doi: 10.1053/j.semperi.2006.05.010
[44]
Luchi JM, Bennett FC, Jackson JC (1991) Predictors of neurodevelopmental outcome following bronchopulmonary dysplasia. Am J Dis Child 145: 813–817. doi: 10.1001/archpedi.1991.02160070109031
[45]
Shepherd EG, Knupp AM, Welty SE, Susey KM, Gardner WP, et al. (2012) An interdisciplinary bronchopulmonary dysplasia program is associated with improved neurodevelopmental outcomes and fewer rehospitalizations. J Perinatol 32: 33–38. doi: 10.1038/jp.2011.45
[46]
Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, et al. (2007) Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 357: 1893–1902. doi: 10.1056/nejmoa073679
[47]
Bhandari V, Finer NN, Ehrenkranz RA, Saha S, Das A, et al. (2009) Synchronized nasal intermittent positive-pressure ventilation and neonatal outcomes. Pediatrics 124: 517–526. doi: 10.1542/peds.2008-1302
[48]
Ehrenkranz RA, Dusick AM, Vohr BR, Wright LL, Wrage LA, et al. (2006) Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 117: 1253–1261. doi: 10.1542/peds.2005-1368
[49]
Ehrenkranz RA, Das A, Wrage LA, Poindexter BB, Higgins RD, et al. (2011) Early nutrition mediates the influence of severity of illness on extremely LBW infants. Pediatr Res 69: 522–529. doi: 10.1203/pdr.0b013e318217f4f1
[50]
Bancalari E, Wilson-Costello D, Iben SC (2005) Management of infants with bronchopulmonary dysplasia in North America. Early Hum Dev 81: 171–179. doi: 10.1016/j.earlhumdev.2004.12.005
[51]
Lagatta JM, Clark RH, Brousseau DC, Hoffmann RG, Spitzer AR (2013) Varying Patterns of Home Oxygen Use in Infants at 23–43 Weeks’ Gestation Discharged from United States Neonatal Intensive Care Units. J Pediatr.
[52]
Sauve RS, McMillan DD, Mitchell I, Creighton D, Hindle NW, et al. (1989) Home oxygen therapy. Outcome of infants discharged from NICU on continuous treatment. Clin Pediatr (Phila) 28: 113–118. doi: 10.1177/000992288902800301
[53]
Moon NM, Mohay HA, Gray PH (2007) Developmental patterns from 1 to 4 years of extremely preterm infants who required home oxygen therapy. Early Hum Dev 83: 209–216. doi: 10.1016/j.earlhumdev.2006.05.015
[54]
Trittmann JK, Nelin LD, Klebanoff MA (2013) Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates. Eur J Pediatr.
[55]
Zanardo V, Freato F (2001) Home oxygen therapy in infants with bronchopulmonary dysplasia: assessment of parental anxiety. Early Hum Dev 65: 39–46. doi: 10.1016/s0378-3782(01)00190-6
[56]
Britton JR (2012) Altitude, oxygen and the definition of bronchopulmonary dysplasia. J Perinatol 32: 880–885. doi: 10.1038/jp.2012.6
